GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genvec Inc (FRA:GVC2) » Definitions » Inventories, Finished Goods

Genvec (FRA:GVC2) Inventories, Finished Goods : €0.00 Mil (As of Mar. 2017)


View and export this data going back to . Start your Free Trial

What is Genvec Inventories, Finished Goods?

Genvec Inventories, Finished Goods Historical Data

The historical data trend for Genvec's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genvec Inventories, Finished Goods Chart

Genvec Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genvec Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genvec Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Genvec (FRA:GVC2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genvec Inc (FRA:GVC2) » Definitions » Inventories, Finished Goods
Comparable Companies
LIFE BBI WAR:PHR LSE:IMM PULM XKRX:299480 XPAR:ALPAT DARE COCP XCNQ:PVOT XKRX:281310 KMPH OSL:SOFTOX-ME BSTG LSE:HVO OSL:NATTO LPTX QNTA ASX:IMC WAR:BML
Traded in Other Exchanges
N/A
Address
Website
http://www.genvec.com
Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear. The Company is currently developing preventative vaccines, against RSV and malaria and therapeutic vaccine against HSV.

Genvec (FRA:GVC2) Headlines

No Headlines